304 filings
Page 4 of 16
4
hkav5o62owrd16m680s
15 Feb 19
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:31pm
SC 13G/A
vgmr77n
14 Feb 19
GW Pharmaceuticals PLC
3:24pm
SC 13G
ze3povg9wd
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
bn8a9q6w74wcyaln8
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
zrqfvy6zhic qdm56jol
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
69lmsuat741 ou
14 Feb 19
GW Pharmaceuticals PLC
12:00am
S-3ASR
6juvehfprw
18 Jan 19
Automatic shelf registration
5:01pm
8-K
xxuyyux
7 Jan 19
Regulation FD Disclosure
6:13am
4
c1cp cj2o31q7s
4 Jan 19
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:15pm
4
0q5rxzxwb0yyu00l0d
26 Dec 18
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:15pm
10-K
js5zbg4vp5
28 Nov 18
Annual report
8:58pm
8-K
kemei8i
27 Nov 18
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
4:05pm
8-K
eb02t35t rgw
26 Nov 18
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
4:15pm
4
29nysfi
23 Nov 18
GW PHARMACEUTICALS / Adam D. George ownership change
4:30pm
8-K
86ack
5 Oct 18
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs
5:08pm
424B5
lw2hk5q
3 Oct 18
Prospectus supplement for primary offering
5:30pm
8-K
hy6 co18t4
1 Oct 18
Other Events
4:14pm
424B5
by8vjzbsn
1 Oct 18
Prospectus supplement for primary offering
4:12pm
3
4xq w5z1qcf
1 Oct 18
GW PHARMACEUTICALS / Thomas G Lynch ownership change
12:00am
3
nyu7 daugn
1 Oct 18
GW PHARMACEUTICALS / Christopher J. Tovey ownership change
12:00am